• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于生理学的药代动力学模型在风险评估中的应用:以拟除虫菊酯为例。

Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids.

机构信息

ScitoVation, LLC, Durham, North Carolina 27713.

Moire Creek Toxicology Consulting Services, Lincoln, California 95648.

出版信息

Toxicol Sci. 2020 Aug 1;176(2):460-469. doi: 10.1093/toxsci/kfaa070.

DOI:10.1093/toxsci/kfaa070
PMID:32421774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7416317/
Abstract

The assessment of potentially sensitive populations is an important application of risk assessment. To address the concern for age-related sensitivity to pyrethroid insecticides, life-stage physiologically based pharmacokinetic (PBPK) modeling supported by in vitro to in vivo extrapolation was conducted to predict age-dependent changes in target tissue exposure to 8 pyrethroids. The purpose of this age-dependent dosimetry was to calculate a Data-derived Extrapolation Factor (DDEF) to address age-related pharmacokinetic differences for pyrethroids in humans. We developed a generic human PBPK model for pyrethroids based on our previously published rat model that was developed with in vivo rat data. The results demonstrated that the age-related differences in internal exposure to pyrethroids in the brain are largely determined by the differences in metabolic capacity and in physiology for pyrethroids between children and adults. The most important conclusion from our research is that, given an identical external exposure, the internal (target tissue) concentration is equal or lower in children than in adults in response to the same level of exposure to a pyrethroid. Our results show that, based on the use of the life-stage PBPK models with 8 pyrethroids, DDEF values are essentially close to 1, resulting in a DDEF for age-related pharmacokinetic differences of 1. For risk assessment purposes, this indicates that no additional adjustment factor is necessary to account for age-related pharmacokinetic differences for these pyrethroids.

摘要

对潜在敏感人群的评估是风险评估的一个重要应用。为了解决与年龄相关的对拟除虫菊酯类杀虫剂敏感性的问题,进行了基于生理学的阶段式(PBPK)建模,通过体外到体内的外推法,预测 8 种拟除虫菊酯在目标组织中的暴露量随年龄的变化。这种与年龄相关的剂量学目的是计算数据衍生外推因子(DDEF),以解决人类拟除虫菊酯类的年龄相关药代动力学差异。我们基于之前发表的大鼠模型,开发了一种通用的人类拟除虫菊酯 PBPK 模型,该模型是使用大鼠体内数据开发的。结果表明,大脑中拟除虫菊酯的内暴露随年龄的差异主要取决于儿童和成人之间代谢能力和拟除虫菊酯生理学方面的差异。我们研究的最重要结论是,对于相同的外部暴露,儿童体内(靶组织)浓度与成人相同或更低,因为接触到相同水平的拟除虫菊酯。我们的研究结果表明,基于使用 8 种拟除虫菊酯的生命阶段 PBPK 模型,DDEF 值基本上接近 1,从而导致年龄相关药代动力学差异的 DDEF 值为 1。对于风险评估目的,这表明对于这些拟除虫菊酯,不需要额外的调整因子来考虑年龄相关的药代动力学差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6023/7416317/6781194ac943/kfaa070f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6023/7416317/352c7eed8860/kfaa070f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6023/7416317/5fd50867450d/kfaa070f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6023/7416317/070f7adcab5d/kfaa070f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6023/7416317/6781194ac943/kfaa070f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6023/7416317/352c7eed8860/kfaa070f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6023/7416317/5fd50867450d/kfaa070f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6023/7416317/070f7adcab5d/kfaa070f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6023/7416317/6781194ac943/kfaa070f4.jpg

相似文献

1
Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids.基于生理学的药代动力学模型在风险评估中的应用:以拟除虫菊酯为例。
Toxicol Sci. 2020 Aug 1;176(2):460-469. doi: 10.1093/toxsci/kfaa070.
2
Evaluation of Age-Related Pyrethroid Pharmacokinetic Differences in Rats: Physiologically-Based Pharmacokinetic Model Development Using In Vitro Data and In Vitro to In Vivo Extrapolation.评估大鼠中与年龄相关的拟除虫菊酯药代动力学差异:使用体外数据和体外到体内外推法开发基于生理学的药代动力学模型。
Toxicol Sci. 2019 Jun 1;169(2):365-379. doi: 10.1093/toxsci/kfz042.
3
Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans.发展和应用基于生活阶段的生理药代动力学(PBPK)模型评估人类体内拟除虫菊酯类的内剂量。
Toxicol Sci. 2020 Jan 1;173(1):86-99. doi: 10.1093/toxsci/kfz211.
4
Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.拟除虫菊酯杀虫剂 QSAR 和 PBPK/PD 模型用于人类风险评估的参数。
Rev Environ Contam Toxicol. 2012;219:1-114. doi: 10.1007/978-1-4614-3281-4_1.
5
PBPK modeling to support risk assessment of pyrethroid exposure in French pregnant women.基于 PBPK 模型支持对法国孕妇接触拟除虫菊酯风险的评估。
Environ Res. 2024 Jun 15;251(Pt 1):118606. doi: 10.1016/j.envres.2024.118606. Epub 2024 Mar 8.
6
Addressing Early Life Sensitivity Using Physiologically Based Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation.使用基于生理学的药代动力学模型和体外到体内外推法解决早期生活敏感性问题。
Toxicol Res. 2016 Jan;32(1):15-20. doi: 10.5487/TR.2016.32.1.015. Epub 2016 Jan 31.
7
Estimating human exposure to pyrethroids' mixtures from biomonitoring data using physiologically based pharmacokinetic modeling.利用基于生理学的药代动力学模型估算人体从生物监测数据中接触拟除虫菊酯混合物的情况。
Environ Res. 2021 Jan;192:110281. doi: 10.1016/j.envres.2020.110281. Epub 2020 Oct 5.
8
Estimating the cumulative human exposures to pyrethroids by combined multi-route PBPK models: Application to the French population.应用联合多途径 PBPK 模型估算人类暴露于拟除虫菊酯类化合物的累积量:以法国人群为例。
Toxicol Lett. 2019 Sep 15;312:125-138. doi: 10.1016/j.toxlet.2019.05.007. Epub 2019 May 9.
9
PBPK models in risk assessment--A focus on chloroprene.风险评估中的生理药代动力学(PBPK)模型——以氯丁二烯为重点
Chem Biol Interact. 2007 Mar 20;166(1-3):352-9. doi: 10.1016/j.cbi.2007.01.016. Epub 2007 Feb 8.
10
Environmentally relevant mixtures in cumulative assessments: an acute study of toxicokinetics and effects on motor activity in rats exposed to a mixture of pyrethroids.环境相关混合物的累积评估:一项急性毒代动力学研究及拟除虫菊酯混合物对暴露于其中的大鼠运动活性的影响
Toxicol Sci. 2012 Dec;130(2):309-18. doi: 10.1093/toxsci/kfs245. Epub 2012 Aug 7.

引用本文的文献

1
In vitro and computational approaches to predict developmental toxicity: Integrating PBPK models with cell-based assays.预测发育毒性的体外和计算方法:将生理药代动力学(PBPK)模型与基于细胞的试验相结合。
Toxicol Appl Pharmacol. 2025 Sep;502:117435. doi: 10.1016/j.taap.2025.117435. Epub 2025 Jun 4.
2
Biomonitoring-Based Risk Assessment of Pyrethroid Exposure in the U.S. Population: Application of High-Throughput and Physiologically Based Kinetic Models.基于生物监测的美国人群拟除虫菊酯暴露风险评估:高通量和基于生理学的动力学模型的应用
Toxics. 2025 Mar 16;13(3):216. doi: 10.3390/toxics13030216.

本文引用的文献

1
Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans.发展和应用基于生活阶段的生理药代动力学(PBPK)模型评估人类体内拟除虫菊酯类的内剂量。
Toxicol Sci. 2020 Jan 1;173(1):86-99. doi: 10.1093/toxsci/kfz211.
2
Evaluation of Age-Related Pyrethroid Pharmacokinetic Differences in Rats: Physiologically-Based Pharmacokinetic Model Development Using In Vitro Data and In Vitro to In Vivo Extrapolation.评估大鼠中与年龄相关的拟除虫菊酯药代动力学差异:使用体外数据和体外到体内外推法开发基于生理学的药代动力学模型。
Toxicol Sci. 2019 Jun 1;169(2):365-379. doi: 10.1093/toxsci/kfz042.
3
Age Dependency of Blood-Brain Barrier Penetration by and -Permethrin in the Rat.
在大鼠中, 和 - 氯菊酯的血脑屏障穿透性的年龄依赖性。
Drug Metab Dispos. 2019 Mar;47(3):234-237. doi: 10.1124/dmd.118.084822. Epub 2018 Dec 6.
4
Current Research on the Safety of Pyrethroids Used as Insecticides.拟除虫菊酯类杀虫剂安全性的研究现状。
Medicina (Kaunas). 2018 Aug 28;54(4):61. doi: 10.3390/medicina54040061.
5
Environmental Chemicals in Breast Milk and Formula: Exposure and Risk Assessment Implications.母乳和配方奶中的环境化学物质:暴露和风险评估的影响。
Environ Health Perspect. 2018 Sep;126(9):96001. doi: 10.1289/EHP1953.
6
Metabolism of deltamethrin and cis- and trans-permethrin by human expressed cytochrome P450 and carboxylesterase enzymes.人源表达的细胞色素P450和羧酸酯酶对溴氰菊酯以及顺式和反式氯菊酯的代谢作用。
Xenobiotica. 2019 May;49(5):521-527. doi: 10.1080/00498254.2018.1474283. Epub 2018 Jun 4.
7
Metabolism of deltamethrin and cis- and trans-permethrin by rat and human liver microsomes, liver cytosol and plasma preparations.溴氰菊酯以及顺式和反式氯菊酯在大鼠和人肝脏微粒体、肝细胞溶质及血浆制剂中的代谢情况。
Xenobiotica. 2019 Apr;49(4):388-396. doi: 10.1080/00498254.2018.1451011. Epub 2018 Apr 19.
8
Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants.通过液相色谱-串联质谱蛋白质组学分析肝羧酸酯酶(CES1和CES2)的年龄依赖性绝对丰度:应用于婴儿体内奥司他韦药代动力学的生理药代动力学模型。
Drug Metab Dispos. 2017 Feb;45(2):216-223. doi: 10.1124/dmd.116.072652. Epub 2016 Nov 28.
9
Locomotor activity and tissue levels following acute administration of lambda- and gamma-cyhalothrin in rats.大鼠急性给予高效氯氟氰菊酯(lambda-和gamma-异构体)后的运动活性和组织水平
Toxicol Appl Pharmacol. 2016 Dec 15;313:97-103. doi: 10.1016/j.taap.2016.10.020. Epub 2016 Oct 26.
10
Plasma protein binding limits the blood brain barrier permeation of the pyrethroid insecticide, deltamethrin.血浆蛋白结合限制了拟除虫菊酯类杀虫剂溴氰菊酯的血脑屏障渗透。
Toxicol Lett. 2016 May 27;250-251:21-8. doi: 10.1016/j.toxlet.2016.03.006. Epub 2016 Mar 22.